This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mondino, A
Right arrow Articles by Comoglio, P M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mondino, A
Right arrow Articles by Comoglio, P M

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 December; 11(12): 6084-6092

Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).

A Mondino, S Giordano and P M Comoglio

Department of Biomedical Sciences, University of Torino Medical School, Italy.

ABSTRACT

The MET proto-oncogene encodes a 190-kDa disulfide-linked heterodimeric receptor (p190 alpha beta) whose tyrosine kinase activity is triggered by the hepatocyte growth factor. The mature receptor is made of two subunits: an alpha chain of 50 kDa and a beta chain of 145 kDa, arising from proteolytic cleavage of a single-chain precursor of 170 kDa (pr170). In a colon carcinoma cell line (LoVo), the precursor is not cleaved and the Met protein is exposed at the cell surface as a single-chain polypeptide of 190 kDa (p190NC). The expression of the uncleaved Met protein is due to defective posttranslational processing, since in this cell line (i) the proteolytic cleavage site Lys-303-Arg-Lys-Lys-Arg-Ser-308 is present in the precursor, (ii) p190NC is sensitive to mild trypsin digestion of the cell surface, generating alpha and beta chains of the correct size, and (iii) the 205-kDa insulin receptor precursor is not cleaved as well. p190NC is a functional tyrosine kinase in vitro and is activated in vivo, as shown by constitutive autophosphorylation on tyrosine. The MET gene is neither amplified nor rearranged in LoVo cells. Overlapping cDNA clones selected from a library derived from LoVo mRNA were sequenced. No mutations were present in the MET-coding region. These data indicate that the tyrosine kinase encoded by the MET proto-oncogene can be activated as a consequence of a posttranslational defect.

Mol Cell Biol. 1991 December; 11(12): 6084-6092




This article has been cited by other articles:

  • Foveau, B., Ancot, F., Leroy, C., Petrelli, A., Reiss, K., Vingtdeux, V., Giordano, S., Fafeur, V., Tulasne, D. (2009). Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis. Mol. Biol. Cell 20: 2495-2507 [Abstract] [Full Text]  
  • Emaduddin, M., Bicknell, D. C., Bodmer, W. F., Feller, S. M. (2008). Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 105: 2358-2362 [Abstract] [Full Text]  
  • Herynk, M. H., Stoeltzing, O., Reinmuth, N., Parikh, N. U., Abounader, R., Laterra, J., Radinsky, R., Ellis, L. M., Gallick, G. E. (2003). Down-Regulation of c-Met Inhibits Growth in the Liver of Human Colorectal Carcinoma Cells. Cancer Res. 63: 2990-2996 [Abstract] [Full Text]  
  • Tam, N.N.C., Chung, S.S.M., Lee, D.T.W., Wong, Y.C. (2000). Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Carcinogenesis 21: 2183-2191 [Abstract] [Full Text]  
  • Trusolino, L., Pugliese, L., Comoglio, P. M. (1998). Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12: 1267-1280 [Abstract] [Full Text]  
  • Lehmann, M., Andre, F., Bellan, C., Remacle-Bonnet, M., Garrouste, F., Parat, F., Lissitsky, J.-C., Marvaldi, J., Pommier, G. (1998). Deficient Processing and Activity of Type I Insulin-Like Growth Factor Receptor in the Furin-Deficient LoVo-C5 Cells. Endocrinology 139: 3763-3771 [Abstract] [Full Text]  
  • Rusciano, D., Lorenzoni, P., Burger, M. M. (1996). Constitutive Activation of c-Met in Liver Metastatic B16 Melanoma Cells Depends on Both Substrate Adhesion and Cell Density and Is Regulated by a Cytosolic Tyrosine Phosphatase Activity. J. Biol. Chem. 271: 20763-20769 [Abstract] [Full Text]  
  • Webb, C., Lane, K, Dawson, A., Vande Woude, G., Warn, R. (1996). C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour. J. Cell Sci. 109: 2371-2381 [Abstract]  
  • Takahashi, S., Nakagawa, T., Kasai, K., Banno, T., Duguay, S. J., Van de Ven, W. J. M., Murakami, K., Nakayama, K. (1995). A Second Mutant Allele of Furin in the Processing-incompetent Cell Line, LoVo. J. Biol. Chem. 270: 26565-26569 [Abstract] [Full Text]  
  • Duguay, S. J., Lai-Zhang, J., Steiner, D. F. (1995). Mutational Analysis of the Insulin-like Growth Factor I Prohormone Processing Site. J. Biol. Chem. 270: 17566-17574 [Abstract] [Full Text]  
  • Wajih, N., Walter, J., Sane, D. C. (2002). Vascular Origin of a Soluble Truncated Form of the Hepatocyte Growth Factor Receptor (c-met). Circ. Res. 90: 46-52 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»